• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    AT&T (T) Offers Free Virtual Healthcare To More Than 100 Million Customers

    Simply Wall St·09/15/2026 23:24:27
    Listen to the news
    • AT&T (NYSE:T) is partnering with LifeMD to offer free virtual healthcare and pharmacy services to eligible wireless and fiber customers.
    • The new program covers primary care, urgent care and dermatology telehealth visits, with access for more than 100 million AT&T subscribers.
    • LifeMD will provide the clinical network and digital platform, while AT&T integrates the service into its consumer plans at no extra cost.
    • The launch of complimentary LifeMD virtual care inside AT&T plans is important, but it is only one part of the story. Check out 4 warning signs (1 major) that AT&T investors should know about.

    For a wider view on how large-scale connectivity and data demand continue to reshape investing themes, it is worth exploring 60 AI infrastructure stocks.

    NYSE:T Earnings & Revenue Growth as at Sep 2026
    NYSE:T Earnings & Revenue Growth as at Sep 2026

    AT&T, a US telecom group with a market cap of about $181.7b, is using its broad connectivity footprint to bundle healthcare access on top of its existing wireless and fiber services, blurring the line between a traditional carrier and a broader consumer utility.

    3 things going right for AT&T that this headline doesn't cover.

    How AT&T’s LifeMD deal pushes its converged-utility story

    AT&T’s investment story hinges on whether heavy spend on fiber, 5G and software-style services can turn basic connectivity into higher value, low churn customer relationships, and this free virtual care bundle plugs straight into that bet.

    "The push toward network convergence (fiber plus 5G) is yielding higher-value, lower-churn subscriber relationships, increasing ARPU and enhancing customer lifetime value, which supports sustainable improvements in net margins and earnings..."

    See how the full story points towards a $29.03 fair value for AT&T.

    The LifeMD partnership tests that convergence thesis in a very visible way. AT&T is trying to use healthcare access as a pull for its fiber and wireless bundles, deepening stickiness rather than competing only on price with Verizon or T Mobile. It leans into the Narrative’s focus on higher value, lower churn accounts, even if the direct financial impact is unclear for now.

    The flip side is the existing concern about capital intensity and earnings expected to decline 1.2% a year over the next 3 years. Giving away a US$19 monthly service widens the customer offer but could squeeze room for margin recovery if usage costs or support needs scale faster than expected. Analysts already flag high debt and heavy investment as risks, so readers should weigh whether this type of bundle justifies the extra strain on free cash flow.

    News like this only really matters when you set it against a clear AT&T Narrative and decide whether it strengthens or weakens the underlying thesis you are relying on.

    Add AT&T to your Watchlist and get alerts as these catalysts play out.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.